Distal 7q11.23 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254351OMIM:613729Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal 7q11.23 microdeletion syndrome (also known as 7q11.23 distal deletion syndrome or Williams-Beuren region duplication syndrome distal deletion) is a rare chromosomal disorder caused by a microdeletion in the distal portion of the 7q11.23 region, adjacent to but distinct from the classic Williams-Beuren syndrome critical region. This deletion typically spans approximately 1.2 Mb and involves several genes including HIP1, YWHAG, and others in the distal flanking region. The syndrome primarily affects neurodevelopment, with key features including speech and language delay, intellectual disability of variable severity, and behavioral difficulties such as attention deficit and autistic features. Affected individuals may also present with seizures or epilepsy, mild facial dysmorphism (which can include a broad forehead, short philtrum, and thin upper lip), and variable congenital anomalies. Some patients exhibit mild cardiovascular abnormalities, though these are less prominent than in Williams syndrome. Growth parameters may be affected, with some individuals showing short stature or microcephaly. There is no specific cure for distal 7q11.23 microdeletion syndrome. Management is supportive and symptom-based, typically involving speech and language therapy, occupational therapy, special educational support, and behavioral interventions. Seizures, when present, are managed with standard antiepileptic medications. Regular developmental assessments and multidisciplinary follow-up are recommended to address the variable clinical manifestations. Genetic counseling is important for affected families, particularly regarding recurrence risk.

Also known as:

Clinical phenotype terms— hover any for plain English:

Porencephalic cystHP:0002132Chiari malformationHP:0002308Bipolar affective disorderHP:0007302
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal 7q11.23 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for Distal 7q11.23 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal 7q11.23 microdeletion syndrome community →

No specialists are currently listed for Distal 7q11.23 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal 7q11.23 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal 7q11.23 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with Distal 7q11.23 microdeletion syndrome.

Start the conversation →

Latest news about Distal 7q11.23 microdeletion syndrome

No recent news articles for Distal 7q11.23 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal 7q11.23 microdeletion syndrome

What is Distal 7q11.23 microdeletion syndrome?

Distal 7q11.23 microdeletion syndrome (also known as 7q11.23 distal deletion syndrome or Williams-Beuren region duplication syndrome distal deletion) is a rare chromosomal disorder caused by a microdeletion in the distal portion of the 7q11.23 region, adjacent to but distinct from the classic Williams-Beuren syndrome critical region. This deletion typically spans approximately 1.2 Mb and involves several genes including HIP1, YWHAG, and others in the distal flanking region. The syndrome primarily affects neurodevelopment, with key features including speech and language delay, intellectual dis

How is Distal 7q11.23 microdeletion syndrome inherited?

Distal 7q11.23 microdeletion syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Distal 7q11.23 microdeletion syndrome typically begin?

Typical onset of Distal 7q11.23 microdeletion syndrome is childhood. Age of onset can vary across affected individuals.